UK markets close in 4 hours 41 minutes

PreveCeutical Medical Inc (18H.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0125+0.0010 (+8.70%)
As of 08:21AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
3.031
Cost of revenue
-
-
-
0
0.779
Gross profit
-
-
-
0
2.252
Operating expenses
Research development
185.37
153.422
171.845
315.141
1,961
Selling general and administrative
592.131
833.714
657.987
1,726
1,368
Total operating expenses
838.994
1,059
897.851
2,163
3,575
Operating income or loss
-838.994
-1,059
-897.851
-2,163
-3,573
Interest expense
-53.774
237.274
466.896
640.042
578.687
Total other income/expenses net
267.703
-185.276
-382.301
-1,004
564.58
Income before tax
-517.517
-1,481
-1,747
-3,807
-3,587
Income tax expense
-
0
-20.477
-6.15
-7.875
Income from continuing operations
-517.517
-1,481
-1,727
-3,801
-3,579
Net income
-517.517
-1,481
-1,727
-3,801
-3,579
Net income available to common shareholders
-517.517
-1,481
-1,727
-3,801
-3,579
Basic EPS
-0.00
-0.00
-0.00
-0.01
-0.01
Diluted EPS
-0.00
-0.00
-0.00
-0.01
-0.01
Basic average shares
517,609
521,790
507,953
455,869
395,746
Diluted average shares
517,609
521,790
507,953
455,869
395,746